Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2/3 1Phase 2 1

Status

Unknown 2Completed 1

Sponsor Class

OTHER 3INDUSTRY 3

Study Type

Interventional 3

Sponsor

Cancer Type

Thoracic 1Gynecologic 1Breast 1

Conditions

Vomiting 3Nausea 2Breast Neoplasms 2Uterine Cervical Neoplasms 1Lung Neoplasms 1

Interventions

Dexamethasone 36Aprepitant 31Palonosetron 27Ondansetron 23Granisetron 14fosaprepitant 13Calcium Dobesilate 12Olanzapine 11Therapeutics 7ramosetron 6dexamethasone acetate 5Tropisetron 5Doxorubicin 5Cyclophosphamide 5Surveys and Questionnaires 4Metoclopramide 4netupitant, palosentron drug combination 3netupitant 3dolasetron 3dexamethasone 21-phosphate 3Yoga 3Vincristine 3Psychiatric Rehabilitation 3Prochlorperazine 3Lorazepam 3Dronabinol 3Diphenhydramine 3Acupressure 3ginger extract 2Thalidomide 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Vomiting × netupitant, palosentron drug combination × Clear all
NCT03668639 2021-12-14

Safety and Antiemetic Efficacy of Akynzeo Plus Dexamethasone During Radiotherapy and Concomitant Weekly Cisplatin

Odense University Hospital

Phase 2/3 Unknown
80 enrolled
Gynecologic

Uterine Cervical Neoplasms, Vomiting

NCT04201769 2020-04-03

LUNG-NEPA

Consorzio Oncotech

Phase 3 Unknown
261 enrolled
Thoracic

Lung Neoplasms, Nausea, Vomiting

NCT03862144 2019-03-05

GIM15-NEPA

Consorzio Oncotech

Phase 2 Completed
150 enrolled
Breast

Breast Neoplasms, Nausea, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon âš¡